Wednesday, November 18, 2026
My Cannabis Art
48.63 °f
Lansing
46.42375 ° Fri
50.50875 ° Sat
  • Login
  • Register
  • Home
    • About Us
    • Affiliate Disclosure
    • Privacy Policy
    • Terms & Disclaimer
  • News
  • Strains
  • Reviews
  • Seeds
  • The Grow Room
    • Start Here
    • Growing Cannabis
    • Strains & Genetics
    • Autoflowers
    • Indoor Growing
    • Grow Equipment
    • Grow Journals
    • Grow Problems
    • Harvest, Dry & Cure
No Result
View All Result
My Cannabis Art
  • Home
    • About Us
    • Affiliate Disclosure
    • Privacy Policy
    • Terms & Disclaimer
  • News
  • Strains
  • Reviews
  • Seeds
  • The Grow Room
    • Start Here
    • Growing Cannabis
    • Strains & Genetics
    • Autoflowers
    • Indoor Growing
    • Grow Equipment
    • Grow Journals
    • Grow Problems
    • Harvest, Dry & Cure
No Result
View All Result
My Cannabis Art
No Result
View All Result
Home News

Congress Holds Hearing On Psychedelics’ Medical Benefits For Military Veterans

by Spendog
November 18, 2026
in News
247 5
0
491
SHARES
1.4k
VIEWS
Share on FacebookShare on BlueskyShare on Threads

RelatedPosts

Alcohol Manufacturers Pushing Congress To Ban Hemp Products Live In Their Own Anti-THC Echo Chamber (Op-Ed)

Alcohol Manufacturers Pushing Congress To Ban Hemp Products Live In Their Own Anti-THC Echo Chamber (Op-Ed)

November 18, 2026
1.4k

GOP Senators Say They’ll Try To Block Any Government Funding Bill That Keeps Hemp THC Products Legal

November 18, 2026
1.4k

How Dispensaries Can Make Green Wednesday Pay Off

November 18, 2026
1.4k

A congressional committee held a hearing about increasing military veterans’ access to psychedelic treatments—with officials from the U.S. Department of Veterans Affairs (VA) testifying alongside medical professionals and researchers.

The hearing—titled “Psychedelic-Assisted Therapies for Veterans: The Path Forward”—was held before the House Veterans’ Affairs Subcommittee on Health on Wednesday.

Rep. Mariannette Miller-Meeks (R-IA), chair of the panel, began the hearing by noting that “emerging research into substances such as MDMA and psilocybin has shown promise for treating PTSD, treatment-resistant depression, and other serious mental health conditions.”

“While more research is needed, these developments should at least give us a reason to be optimistic,” she said. “Fortunately, the VA is uniquely positioned to help lead this effort. With one of the largest integrative healthcare systems in the country, a robust research enterprise and decades of experience treating veterans with complex mental health conditions, the VA has the capabilities to help move these therapies from research toward clinical practice.”

The congresswoman, who is a physician, noted that she never imagined herself supporting psychedelic therapy when she entered Congress in 2021, but said after “meeting with veterans from all walks of life, I have found the effectiveness of these treatments and am willing to advance it as potential hope.”

“If these emerging therapies can help improve outcomes, restore hope, and save lives, then we owe it to our veterans to responsibly pursue this opportunity,” Miller-Meeks said. “They have earned nothing less.”

Rep. Julia Brownley (D-CA), the Democratic ranking member on the subcommittee, noted that the hearing comes at “a very pivotal moment for veterans and lawmakers interested in psychedelic-assisted treatments.”

“We are on the cusp of seeing [Food and Drug Administration] approval for psychedelic compound to treat mental health conditions at a time when we have not seen a novel treatment approved for mental health conditions for many years,” she said. “This is extremely welcome news and will change lives for the better.

Brownley cautioned, however, that psychedelics, like other treatments, “will not be a panacea for everyone, and particularly not for every veteran.”

“It’s also important that VA is ready to contend with the growth in private sector providers that will inevitably occur in response to the massive demand for psychedelics once these drugs receive FDA approval,” she said. “As we have already seen with other treatments, such as ketamine being prescribed off-label for depression, the entry of psychedelics to the market will likely lead to growth in the industry of wellness centers centers marketing themselves to veterans. It will be critical for VA to carefully develop criteria for any provider of psychedelic-assisted treatments to be able to join its community care network.”


YouTube video player

Andrew Gradison, a senior advisor to the under secretary for health at the VA’s Veterans Health Administration (VHA), said in testimony for the hearing that President Donald Trump’s administration “has taken decisive action to accelerate psychedelic research and eliminate regulatory obstacles that have historically slowed progress.”

He cited an executive order Trump signed in April with the aim of expediting psychedelic therapy access, saying it was the “first EO in American history dedicated specifically to accelerating clinical research and regulatory review of psychedelics, underscoring the president’s firm commitment to advancing emerging treatments for serious mental illnesses.”

Since then, “VA’s psychedelics research portfolio has grown substantially in response, and our interagency partnerships are driving rapid and safe scientific advancement,” Gradison said, noting that it is now conducting 21 active clinical studies on psychedelics to treat mental health conditions.

He specifically cited a clinical trial VA announced in August to investigate whether psilocybin can help military veterans who are struggling with treatment-resistant depression.

🇺🇸WATCH🇺🇸

“This is very helpful, especially for the wounds of war that are sometimes not seen, as we know with PTSD. I am glad to see that we are leading the effort, and this is what the American people demand.”

Congressman Hamadeh’s Opening Remarks at today’s @HouseVetAffairs… pic.twitter.com/omv88q2NQi

— Office of Congressman Abe Hamadeh (@RepAbeHamadeh) November 18, 2026

“VA strives to lead the Nation in exploring the therapeutic potential of psychedelic drugs,” Gradison said, adding that the department recognizes that substances such as psilocybin, MDMA and ibogaine “offer promising potential for the complex mental health conditions affecting many of the Veterans we treat.”

The VA official also touted a memorandum of understanding his department signed with the Department of Health and Human Services (HHS) in July outlining a partnership to collaborate on research and development of psychedelic medicines to treat people struggling with serious mental health conditions.

The agreement, he said “lays the groundwork for unprecedented VA-HHS operational cooperation on psychedelic trials.”

“As we prepare for potential clinical implementation, VA remains anchored in three core priorities: first, ensuring Veteran safety above all else; second, building a rigorous body of evidence to determine which treatments work for which Veterans; and third, laying the foundation so that, pending all regulatory approvals, VA is positioned to be the first health care system in the Nation to deliver these treatments to Veterans. These priorities shape every research, clinical, and policy decision we make in this space.”

Gradison said VA has already identified 10 facilities “with the expertise, physical space, and operational capacity needed to serve as early implementers, educators, or sites-in-training” with teams that are “experienced in psychedelic research protocols and are preparing to translate that experience into clinical care that maximizes Veterans’ safety if treatments are approved.”

The VA official emphasized, however, that the department discourages self-medicating with psychedelics or using them to replace other mental health treatment options.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Become a patron at Patreon!



Source link

Share196ShareShare

Related Posts

Alcohol Manufacturers Pushing Congress To Ban Hemp Products Live In Their Own Anti-THC Echo Chamber (Op-Ed)

Alcohol Manufacturers Pushing Congress To Ban Hemp Products Live In Their Own Anti-THC Echo Chamber (Op-Ed)

by Spendog
November 18, 2026
0
1.4k

“Alcohol manufacturers are the only tier of their own industry asking Congress to kill a category that Forbes has called...

GOP Senators Say They’ll Try To Block Any Government Funding Bill That Keeps Hemp THC Products Legal

GOP Senators Say They’ll Try To Block Any Government Funding Bill That Keeps Hemp THC Products Legal

by Spendog
November 18, 2026
0
1.4k

Two Republican senators are saying they will not support passage of any bill to keep the federal government funded if...

How Dispensaries Can Make Green Wednesday Pay Off

How Dispensaries Can Make Green Wednesday Pay Off

by Spendog
November 18, 2026
0
1.4k

Green Wednesday is notorious for some of the steepest sales and discounts of the year and can be a great...

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *


POPULAR

  • ILGM Beginner Mix cannabis seeds

    ILGM Beginner Mix: White Widow, AK-47 & Bubble Gum

    495 shares
    Share 198 Tweet 124
  • Granddaddy Purple Feminized Seeds: Genetics, Growing & Strain Guide

    494 shares
    Share 198 Tweet 124
  • Sour Diesel Feminized Seeds: Genetics, Growing & Strain Guide

    494 shares
    Share 198 Tweet 124
  • ILGM Autoflower 2.0 Mix: Bubblegum, Jack Herer & OG Kush Autos

    493 shares
    Share 197 Tweet 123
  • The Science Behind Cannabis as a Potential Treatment for ADHD

    496 shares
    Share 197 Tweet 123

About Us

My Cannabis Art is an independent cannabis genetics and growing publication focused on seeds, strains, cultivation, and the science behind the plant. We aim to make cannabis information easier to understand through practical guides, genetics research, and honest product coverage for adults 21+.

Recent News

Congress Holds Hearing On Psychedelics’ Medical Benefits For Military Veterans

Congress Holds Hearing On Psychedelics’ Medical Benefits For Military Veterans

November 18, 2026
Alcohol Manufacturers Pushing Congress To Ban Hemp Products Live In Their Own Anti-THC Echo Chamber (Op-Ed)

Alcohol Manufacturers Pushing Congress To Ban Hemp Products Live In Their Own Anti-THC Echo Chamber (Op-Ed)

November 18, 2026

Category

  • Autoflower Seeds
  • Cannabis Knowledge
  • Feminized Seeds
  • Genetics & Science
  • Hybrid
  • Indica
  • Indoor Growing
  • Mix Packs
  • News
  • Outdoor Growing
  • Sativa
  • Seeds
  • Strains
  • About
  • Advertise
  • Privacy & Policy
  • Contact
  • Imprint
  • Cookie Policy
  • Privacy Statement
  • Cookie Policy (US)
  • Privacy Statement (US)
  • Cookie Policy (EU)
  • Privacy Statement (EU)
  • Cookie Policy (UK)
  • Privacy Statement (UK)
  • Cookie Policy (CA)
  • Privacy Statement (CA)

© 2026 My Cannabis Art. All rights reserved. Seeds, Genetics & the Art of Growing.

Welcome Back!

Sign In with Facebook
Sign In with Google
Sign In with Linked In
OR

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Sign Up with Facebook
Sign Up with Google
Sign Up with Linked In
OR

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
My Cannabis Art
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
My Cannabis Art
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
No Result
View All Result
  • Home
    • Privacy Policy
    • About Us
    • Contact
    • Cookie Policy (CA)
    • Cookie Policy (EU)
    • Cookie Policy (UK)
    • Cookie Policy (US)
    • Privacy Statement (CA)
    • Privacy Statement (EU)
    • Privacy Statement (UK)
    • Privacy Statement (US)
    • Terms & Disclaimer
  • News
  • Cannabis Knowledge
  • Genetics & Science
  • Growing
  • Seeds
  • Strains

© 2026 My Cannabis Art. All rights reserved. Seeds, Genetics & the Art of Growing.

Are you 21 or older?

My Cannabis Art contains cannabis-related content intended for adults 21 and older. Please confirm your age to continue.

Yes, I’m 21 or Older
No, I’m Under 21